Vaxcyte, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Grant E. Pickering, with a market cap of $8.7B.
Common questions about Vaxcyte, Inc.
Vaxcyte, Inc. is scheduled to report earnings for Q1 2026 on May 6, 2026 after market close. Analysts estimate revenue of $12.5M.
Vaxcyte, Inc. has approximately 254 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.